The global biobanking market could be valued at US$43.9 billion in fiscal year 2023 from US$41 billion in 2023 . Over the past year, the industry has registered a year-on-year increase of 7.2% . From 2023 to 2033, biobanking sales are expected to thrive at a CAGR of 7.25%, reaching a value of US$88 billion by the end of 2033 .
This part of the offer comes with many open doors, including item manufacturing, diversion, retail, and display management. Fact.MR examiners have utilized extensive mandatory and extensive optional research to make various assessments and projections of demand in the biobanking market, both at the global and local levels.
Download a sample copy of this report : –https://www.factmr.com/connectus/sample?flag=S&rep_id=4438
Market players: –
- Thermo Fisher Scientific
- Tekan Group Co., Ltd.
- Qiagen NV
- Hamilton Company
- Brooks Automation
- TTP Labotech Co., Ltd.
- VWR Corporation
- Promega
- Worthington Industries
- chart industry
- Becton Dickinson and Company
- Merck KGaA
Examiners utilized a wide variety of business knowledge devices to integrate reality, numbers, and market information to assess and predict market revenue.
Key partners in the market, including industry players, policy makers and financial backers in various countries, have continually recalibrated their systems and tactics to take advantage of the newly opened doors. Many organizations have recently updated their procedures to stay coordinated during the overall chaos wrought by the COVID-19 pandemic.
Key Segments Covered by Industry Research
· By storage
-
- manual
- automatic
· Depending on the application
-
- Therapeutics
- clinical diagnosis
- Drug discovery and development
- others
· By biological sample
-
- blood products
- human tissue
- cell line
- nucleic acid
- others
・ By product
-
- Device
- temperature control system
- freezer and refrigerator
- cryogenic storage system
- defrosting device
- Incubators and centrifuges
- Alarm and monitoring system
- Accessories and other equipment
- the expendables
- cryovials and cryomolds
- tube
- others
- Device
・ By region
-
- North American market
- latin american market
- european market
- Asia Pacific market
- Middle East/Africa Market
What do you get with Fact.MR research?
- Factors influencing the overall development of the global biobanking market
- Factors that may restrain the growth of the global market in the coming years of the forecast period.
- What are its complex details regarding the current competitive scenario of the global Biobanking market and the potential business prospects of the key market players?
- Pricing strategies of several different market players in the global biobanking market
Regional analysis includes
- North America (USA, Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Republic, etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, Korea, ASEAN Countries, Rest of APEJ)
How does Fact.MR help with strategic moves?
The data provided in the biobanking market report offers a comprehensive analysis of key industry trends. Industry insiders can use this data to strategize potential business moves to generate impressive returns in the upcoming period.
The report covers price trend analysis and value chain analysis, as well as analysis of various products by market players. The primary purpose of this report is to assist companies in making data-driven decisions and strategizing their business moves.